# ConnectOne Bancorp, Inc.: financial statements, quarterly

CNOB · Nasdaq · CIK 712771 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cnob.md) · [Financials](/companies/cnob/financials.md) · [Filings](/companies/cnob/filings.md) · [Insiders](/companies/cnob/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cnob/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [61.3](/filings/0001437749-25-004744.md) | [67.1](/filings/0001437749-25-004744.md) | [69.3](/filings/0001437749-26-005320.md) | [68.6](/filings/0001437749-26-005320.md) | [69.4](/filings/0001437749-26-005320.md) | [63.3](/filings/0001437749-26-005320.md) | [59.0](/filings/0001437749-26-005320.md) | [67.1](/filings/0001437749-26-005320.md) | [85.7](/filings/0001437749-26-005320.md) | [79.7](/filings/0001437749-26-005320.md) | not reported | not reported |
| Income tax | $m | [7.2](/filings/0001437749-25-004744.md) | [6.2](/filings/0001437749-25-004744.md) | [5.9](/filings/0001437749-26-005320.md) | [6.7](/filings/0001437749-26-005320.md) | [6.0](/filings/0001437749-26-005320.md) | [6.1](/filings/0001437749-26-005320.md) | [7.2](/filings/0001437749-26-014866.md) | [(5.0)](/filings/0001437749-26-025623.md) | [16.3](/filings/0001437749-26-005320.md) | [13.9](/filings/0001437749-26-005320.md) | [14.7](/filings/0001437749-26-014866.md) | [16.2](/filings/0001437749-26-025623.md) |
| Net income | $m | [21.4](/filings/0001437749-25-004744.md) | [19.3](/filings/0001437749-25-004744.md) | [17.2](/filings/0001437749-26-005320.md) | [19.1](/filings/0001437749-26-005320.md) | [17.2](/filings/0001437749-26-005320.md) | [20.4](/filings/0001437749-26-005320.md) | [20.2](/filings/0001437749-26-014866.md) | [(20.3)](/filings/0001437749-26-025623.md) | [41.0](/filings/0001437749-26-005320.md) | [39.5](/filings/0001437749-26-005320.md) | [37.8](/filings/0001437749-26-014866.md) | [41.7](/filings/0001437749-26-025623.md) |
| Diluted EPS | $ per share | [0.51](/filings/0001437749-25-004744.md) | [0.46](/filings/0001437749-25-004744.md) | [0.41](/filings/0001437749-26-005320.md) | [0.46](/filings/0001437749-26-005320.md) | [0.41](/filings/0001437749-26-005320.md) | [0.49](/filings/0001437749-26-005320.md) | [0.49](/filings/0001437749-26-014866.md) | [(0.52)](/filings/0001437749-26-025623.md) | [0.78](/filings/0001437749-26-005320.md) | [0.75](/filings/0001437749-26-005320.md) | [0.72](/filings/0001437749-26-014866.md) | [0.80](/filings/0001437749-26-025623.md) |
| Basic EPS | $ per share | [0.51](/filings/0001437749-25-004744.md) | [0.46](/filings/0001437749-25-004744.md) | [0.41](/filings/0001437749-26-005320.md) | [0.46](/filings/0001437749-26-005320.md) | [0.41](/filings/0001437749-26-005320.md) | [0.49](/filings/0001437749-26-005320.md) | [0.49](/filings/0001437749-26-014866.md) | [(0.52)](/filings/0001437749-26-025623.md) | [0.79](/filings/0001437749-26-005320.md) | [0.76](/filings/0001437749-26-005320.md) | [0.72](/filings/0001437749-26-014866.md) | [0.80](/filings/0001437749-26-025623.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001437749-23-030213.md) | [0.2](/filings/0001437749-25-004744.md) | [0.3](/filings/0001437749-24-014647.md) | [0.3](/filings/0001437749-24-024478.md) | [0.2](/filings/0001437749-24-033329.md) | [0.4](/filings/0001437749-26-005320.md) | [0.3](/filings/0001437749-25-014321.md) | [0.6](/filings/0001437749-25-025881.md) | [0.5](/filings/0001437749-25-032796.md) | [0.4](/filings/0001437749-26-025623.md) | [0.3](/filings/0001437749-26-014866.md) | [0.4](/filings/0001437749-26-025623.md) |
| Total assets | $bn | [9.7](/filings/0001437749-23-030213.md) | [9.9](/filings/0001437749-26-005320.md) | [9.9](/filings/0001437749-25-014321.md) | [9.7](/filings/0001437749-25-025881.md) | [9.6](/filings/0001437749-25-032796.md) | [9.9](/filings/0001437749-26-005320.md) | [9.8](/filings/0001437749-26-014866.md) | [13.9](/filings/0001437749-25-025881.md) | [14.0](/filings/0001437749-25-032796.md) | [14.0](/filings/0001437749-26-025623.md) | [14.2](/filings/0001437749-26-014866.md) | [14.4](/filings/0001437749-26-025623.md) |
| Total liabilities | $bn | [8.5](/filings/0001437749-23-030213.md) | [8.6](/filings/0001437749-25-004744.md) | [8.6](/filings/0001437749-24-014647.md) | [8.5](/filings/0001437749-24-024478.md) | [8.4](/filings/0001437749-24-033329.md) | [8.6](/filings/0001437749-26-005320.md) | [8.5](/filings/0001437749-25-014321.md) | [12.4](/filings/0001437749-25-025881.md) | [12.5](/filings/0001437749-25-032796.md) | [12.4](/filings/0001437749-26-025623.md) | [12.6](/filings/0001437749-26-014866.md) | [12.8](/filings/0001437749-26-025623.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.2](/filings/0001437749-24-033329.md) | [1.2](/filings/0001437749-26-005320.md) | [1.2](/filings/0001437749-25-025881.md) | [1.2](/filings/0001437749-25-032796.md) | [1.2](/filings/0001437749-25-032796.md) | [1.2](/filings/0001437749-26-025623.md) | [1.3](/filings/0001437749-26-025623.md) | [1.5](/filings/0001437749-26-025623.md) | [1.5](/filings/0001437749-25-032796.md) | [1.6](/filings/0001437749-26-025623.md) | [1.6](/filings/0001437749-26-025623.md) | [1.6](/filings/0001437749-26-025623.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [26.9 d](/filings/0001437749-24-033329.md) | [28.3 d](/filings/0001437749-26-005320.md) | [20.5](/filings/0001437749-25-014321.md) | [22.3 d](/filings/0001437749-25-025881.md) | [(14.4) d](/filings/0001437749-25-032796.md) | [32.2 d](/filings/0001437749-26-005320.md) | [14.9](/filings/0001437749-26-014866.md) | [6.5 d](/filings/0001437749-26-025623.md) | [37.4 d](/filings/0001437749-25-032796.md) | [47.7 d](/filings/0001437749-26-005320.md) | [15.3](/filings/0001437749-26-014866.md) | [34.5 d](/filings/0001437749-26-025623.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001437749-24-033329.md) | [3.5 d](/filings/0001437749-26-005320.md) | [0.1](/filings/0001437749-25-014321.md) | [0.1 d](/filings/0001437749-25-025881.md) | [1.3 d](/filings/0001437749-25-032796.md) | [2.3 d](/filings/0001437749-26-005320.md) | [0.3](/filings/0001437749-26-014866.md) | [0.1 d](/filings/0001437749-26-025623.md) | [3.5 d](/filings/0001437749-25-032796.md) | [1.6 d](/filings/0001437749-26-005320.md) | [1.3](/filings/0001437749-26-014866.md) | [0.8 d](/filings/0001437749-26-025623.md) |
| Dividends paid | $m | [6.6 d](/filings/0001437749-24-033329.md) | [6.6 d](/filings/0001437749-26-005320.md) | [6.5](/filings/0001437749-25-014321.md) | [6.9 d](/filings/0001437749-25-025881.md) | [6.9 d](/filings/0001437749-25-032796.md) | [6.9 d](/filings/0001437749-26-005320.md) | [6.9](/filings/0001437749-26-014866.md) | [6.9 d](/filings/0001437749-26-025623.md) | [9.1 d](/filings/0001437749-25-032796.md) | [9.1 d](/filings/0001437749-26-005320.md) | [9.1](/filings/0001437749-26-014866.md) | [9.8 d](/filings/0001437749-26-025623.md) |
| Share repurchases | $m | [6.2 d](/filings/0001437749-24-033329.md) | [2.2 d](/filings/0001437749-26-005320.md) | [5.8](/filings/0001437749-25-014321.md) | [0.0 d](/filings/0001437749-25-025881.md) | [0.0 d](/filings/0001437749-25-032796.md) | [0.0 d](/filings/0001437749-26-005320.md) | [0.0](/filings/0001437749-26-014866.md) | [0.0 d](/filings/0001437749-26-025623.md) | [0.0 d](/filings/0001437749-25-032796.md) | [0.0 d](/filings/0001437749-26-005320.md) | [2.4](/filings/0001437749-26-014866.md) | [0.0 d](/filings/0001437749-26-025623.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.3](/filings/0001437749-23-030213.md) | [39.3](/filings/0001437749-24-014647.md) | [39.0](/filings/0001437749-24-024478.md) | [38.8](/filings/0001437749-24-033329.md) | [38.5](/filings/0001437749-25-014321.md) | [38.4](/filings/0001437749-25-025881.md) | [38.5](/filings/0001437749-25-032796.md) | [38.5](/filings/0001437749-26-014866.md) | [42.0](/filings/0001437749-26-025623.md) | [50.5](/filings/0001437749-25-032796.md) | [50.4](/filings/0001437749-26-014866.md) | [50.4](/filings/0001437749-26-025623.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 50,319,832 at 2026-08-04, from the cover of the [10-Q/A filed 2026-08-18](/filings/0001437749-26-028359.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.